When was Linus Biotechnology founded?

Linus Biotechnology was founded in 2020 and raised its 1st funding round 2 years after it was founded.

Where is Linus Biotechnology located?

Linus Biotechnology is headquartered in New York City, United States.

How many employees does Linus Biotechnology have?

As of Aug 31, 2026, the latest employee count at Linus Biotechnology is 31.

Is Linus Biotechnology a funded company?

Linus Biotechnology is a funded company, having raised a total of $47.6M across 4 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Mar 21, 2022.

When was the latest funding round of Linus Biotechnology?

Linus Biotechnology's latest funding was a $***** Series A round on Jul 29, 2024, with participation from 0 investor. Its primary sector is Neurology. In United States, the Neurology sector has seen $4.05B in funding in 2026 to date.

Where does Linus Biotechnology rank among its competitors?

Linus Biotechnology ranks 1st amongst 15 active competitors, of which 5 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was MARAbio, which secured $19.1M in Sep, 2024.

Who are the top competitors of Linus Biotechnology?

Linus Biotechnology's top competitors include MARAbio, Lineagen and SynapDx. Among them, MARAbio secured the most recent funding round in September, 2024.

Linus Biotechnology - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of diagnostic tests for central nervous system and gastrointestinal disorders. The company offers StrandDx ASD, a non-invasive diagnostic aid for Autism Spectrum Disorder. The company's pipeline comprises precision exposome medicine biomarkers and target discovery across gastroenterology, renal disease and oncology.

Website: www.linusbio.com/
Social

Key Metrics

Founded Year

2020

Location

New York City, United States

Stage

Series A

Total Funding

$47.6M in 4 rounds

Latest Funding Round

Series A, Jul 29, 2024, $*****

Investors

GreatPoint Ventures & 4 more

Ranked

1^st among 15 active competitors

Employee Count

31 as on Aug 31, 2026

Similar Companies

MARAbio & 14 more

View Linus Biotechnology's full profile

Linus Biotechnology has raised a total funding of $47.6M over 4 rounds. Its first funding round was on Mar 21, 2022. Linus Biotechnology has 4 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Linus Biotechnology:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 29, 2024	1153911	Series A	3682549	1377926	8186023	4122547
May 25, 2023	8633964	Series A	6837979	2433052	4711068	Yac
Jan 06, 2023	1750872	Series A	4254064	8913596	GreatPoint Ventures & 1 more	Divergent Investments & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of Linus Biotechnology's funding rounds and investors

The founders of Linus Biotechnology are Christine Austin and Paul Curtin.

Here are the details of Linus Biotechnology's key team members:

Christine Austin: Co-Founder of Linus Biotechnology.
Contact Info: 1 email address
Paul Curtin: Co-Founder of Linus Biotechnology.
Contact Info: 1 email address

View details of Linus Biotechnology's Founder profiles and Board Members

Linus Biotechnology's employee count trend

Linus Biotechnology has 31 employees as of Aug 26. Here is Linus Biotechnology's employee count trend over the years:

Employee count trend for Linus Biotechnology

Uncover Linus Biotechnology's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Linus Biotechnology include MARAbio, Lineagen and SynapDx. Here is the list of Top 10 competitors of Linus Biotechnology, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Linus Biotechnology 2020, New York City (United States), Series A	Developer of diagnostic tests for central nervous system and gastrointestinal disorders	$47.6M	GreatPoint Ventures, Bow Capital & 3 others	54/100
2nd	MARAbio 2016, Salt Lake City (United States), Series A	Developer of blood test for detecting maternal autoantibody-related autism	$19.1M	MAK Capital, Moai Capital	50/100
3rd	Lineagen 2002, Salt Lake City (United States), Acquired	Sequencing-based diagnostic test and consultative services for autism	$66.9M	Health Quest Capital, Mesa Verde Venture Partners ... & 10 others	46/100
4th	SynapDx 2010, Southborough (United States), Deadpooled	Developer of blood-based diagnostic tests for the early detection of autism	$32.8M	Google Ventures, North Bridge Venture Partners ... & 7 others	38/100
5th	FBB Biomed 2020, Coralville (United States), Seed	Developer of in-vitro diagnostic test for COVID-19 and neurological diseases	$401K	-	28/100
6th	Leeza 2023, Hyderabad (India), Unfunded	AI-powered screening assessments for the early detection of autism	-	-	27/100
7th	BioROSA Technologies 2018, Boston (United States), Seed	Developer of blood tests for early detection of Autism Spectrum Disorder	$1.03M	IndieBio, OCA Ventures & 2 others	26/100
8th	SensOmics 2007, Toronto (Canada), Seed	Provider of precision medicine for children's health	-	iSeed Ventures, Asset Management Ventures	26/100
9th	Pediatric Bioscience 2006, Sacramento (United States), Deadpooled	Blood biomarker based diagnostics for Autism Spectrum Disorders	$2.44M	Tech Coast Angels, Arizona Tech Investors	24/100
10th	Nevarra Labs 2026, Austria, Unfunded	Developer of blood tests identifying biomarkers for neurological health conditions	-	-	24/100